Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells-Reference-Cited by-同舟云学术

Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells

Published:2016-01-30 Issue:9 Volume:7 Page:10638-10649
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

An Na¹,Tao Zhongfei¹,Li Saisai¹,Xing Haiyan¹,Tang Kejing¹,Tian Zheng¹,Rao Qing¹,Wang Min¹,Wang Jianxiang¹

Affiliation:

1. State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies;Blood Reviews;2024-09

2. A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells;Cellular Oncology;2024-07-15

3. Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity;Cell Stem Cell;2024-07

4. Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma;Journal for ImmunoTherapy of Cancer;2024-04

5. A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells;2024-02-07